| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |